Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    1880
    PDF: 836
    HTML: 1271
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5386
    PDF: 2275
    HTML: 1310
  • Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19

    Fehmi Hindilerden, Ipek Yonal-Hindilerden, Emre Akar, Zuhal Yesilbag, Kadriye Kart-Yasar
    e2020053
    2020-09-14
    https://doi.org/10.4084/mjhid.2020.053
    3048
    PDF: 1536
    HTML: 248
  • Sickle Cell Disease: Management options and challenges in developing countries

    Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong
    e2013062
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.062
    2364
    PDF: 1223
    HTML: 989
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2608
    PDF: 3110
    HTML: 332
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1242
    PDF: 711
    HTML: 1387
  • Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma

    Karin Petra Sabine Langenberg-Ververgaert, Ronald M. Laxer, Angela S. Punnett, Lee L Dupuis, Yaron Finkelstein, Oussama Abla
    e2018019
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.019
    2745
    PDF: 779
    HTML: 387
  • REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

    Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst
    e2021012
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.012
    1485
    PDF: 562
    HTML: 170
  • PREVALENCE AND MOLECULAR CHARACTERIZATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN FEMALES FROM PREVIOUSLY MALARIA ENDEMIC REGIONS IN NORTHEASTERN THAILAND AND IDENTIFICATION OF A NOVEL G6PD VARIANT

    Sumalai Dechyotin, Kittipong Sakunthai, Noppmats Khemtonglang, Supawadee Yamsri, Kanokwan Sanchaisuriya, Kriengkrai Kitcharoen, Suttiphan Kitcharoen
    Page e2021029
    2021-04-30
    https://doi.org/10.4084/MJHID.2021.029
    1852
    PDF: 596
    HTML: 224
  • 30 YEARS RETROSPECTIVE REVIEW OF TUBERCULOSIS CASES IN A TUBERCULOSIS DISPENSARY IN BURSA/NILUFER, TURKEY (1985-2014)

    Kayıhan PALA, Harika GERÇEK, Tuncay AYDIN TAŞ, Rukiye ÇAKIR, Sedef ÖZGÜÇ, Timur YILDIZ
    e2016059
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.059
    3210
    PDF: 792
    HTML: 1724
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    2744
    PDF: 823
    HTML: 6500
    Untitled: 206
    Untitled: 169
    Untitled: 171
    Untitled: 192
  • MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

    Ibrahim C. Haznedaroglu
    e2014009
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.009
    3833
    PDF: 1443
    HTML: 9173
    Untitled: 259
    Untitled: 163
    Untitled: 149
    Untitled: 145
    Untitled: 163
    Untitled: 316
  • GOOD OUTCOME FOR VERY HIGH RISK ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA CARRYING GENETIC ABNORMALITIES t(4;11)(q21;q23) or t(9;22)(q34;q11), IF PROMPTLY SUBMITTED TO ALLOGENEIC TRANSPLANTATION, AFTER OBTAINING A GOOD MOLECULAR REMISSION.

    Matteo Parma, Clara Vigano', Monica Fumagalli, Federica Colnaghi, Arianna Colombo, Federica Mottadelli, Vincenzo Rossi, Elena Elli, Elisabetta Terruzzi, Angelo Belotti, Giovanni Cazzaniga, Enrico Maria Pogliani, Pietro Pioltelli
    e2015041
    2015-05-26
    https://doi.org/10.4084/mjhid.2015.041
    2131
    PDF: 1000
    HTML: 1177
  • COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Stefan Hohaus, Luciana Teofili, Mario Balducci, Stefania Manfrida, Angelo Pompucci, Francesco D'Alo', Giuseppina Massini, Luigi Maria Larocca, Roberto Marra, Sergio Storti
    e2009020
    2009-12-14
    https://doi.org/10.4084/mjhid.2009.020
    2046
    PDF: 518
    HTML: 2273
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1193
    PDF: 766
    HTML: 526
  • WHO HAS THERAPY-RELATED AML?

    Robert Gale, John M. Bennett, F. Owen Hoffman
    e2017025
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.025
    3047
    PDF: 4274
    HTML: 772
  • MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA

    Alessandro Granito, Luigi Bolondi
    e2009021
    https://doi.org/10.4084/mjhid.2009.021
    705
    PDF: 454
    HTML: 6247
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1331
    PDF: 585
    HTML: 227
  • SOCIAL AND FINANCIAL BARRIERS TO OPTIMUM TKI TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA- A KNOWLEDGE-ATTITUDES-PRACTICES STUDY FROM INDIA

    Naveen Gupta, Manoranjan Mahapatra, Tulika Seth, Seema Tyagi, Sudha Sazawal, Renu Saxena
    e2021004
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.004
    1603
    PDF: 476
    HTML: 217
  • CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

    Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi
    e2010017
    2010-06-18
    https://doi.org/10.4084/mjhid.2010.017
    1610
    PDF: 699
    HTML: 2327
  • PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

    Fiorina Giona
    e2021069
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.069
    1759
    HTML: 1372
    PDF: 1031
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1304
    HTML: 370
    PDF: 793
  • PROTECTIVE ROLE OF SYLIMARIN ON METHOTREXATE INDUCED HEPATO-NEPHROTOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2016043
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.043
    3505
    PDF: 992
    HTML: 1262
  • PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

    Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus
    e2014053
    2014-07-04
    https://doi.org/10.4084/mjhid.2014.053
    3193
    PDF: 1910
    HTML: 7453
  • Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: case report and literature review

    Toshifumi Takahashi
    e2020005
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.005
    1693
    PDF: 1143
    HTML: 270
  • ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

    Jialian Li
    e2019036
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.036
    1923
    PDF: 1407
    HTML: 206
  • THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

    Evi Stavrou, Hillard Michael Lazarus
    e2010033
    2010-10-29
    https://doi.org/10.4084/mjhid.2010.033
    1530
    PDF: 1020
    HTML: 10428
  • In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

    Jochen J Frietsch, Detlef Michel, Thomas Stamminger, Friederike Hunstig, Sebastian Birndt, Ulf Schnetzke, Sebastian Scholl, Andreas Hochhaus, Inken Hilgendorf
    e2019001
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.001
    2247
    PDF: 1383
    HTML: 236
  • Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature

    Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Capolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Alessandro Maria Vannucchi, Alessandro Bartoloni
    e2023028
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.028
    904
    PDF: 726
    HTML: 317
  • CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia

    Xiaoyuan Gong, mianzeng yang, Dong Lin, Hui Wei, Ying Wang, Bingchen Liu, Chunlin Zhou, Kaiqi Liu, Shuning Wei, Benfa Gong, Guancji Zhang, Yuntao Liu, Yan Li, Xingli Zao, Shaowei Qiu, Ruxia Gu, Yingchang Mi, Jianxiang Wang
    e2020003
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.003
    1636
    PDF: 908
    HTML: 210
  • DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

    Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà
    e2018040
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.040
    3562
    PDF: 1254
    HTML: 702
    Figure 2: 423
    Figure 1: 3090
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    1778
    PDF: 691
    HTML: 2084
    Untitled: 192
    Untitled: 139
    Untitled: 152
    Untitled: 141
    Untitled: 145
    Untitled: 161
    Untitled: 168
  • PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD

    Beatrice Autino, Yolanda Corbett, Francesco Castelli, Donatella Taramelli
    e2012061
    2012-10-04
    https://doi.org/10.4084/mjhid.2012.061
    4341
    PDF: 1872
    HTML: 17710
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    747
    PDF: 542
    HTML: 2443
  • THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

    Nicola Semeraro, Prof. Mario Colucci
    e2021045
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.045
    1879
    PDF: 773
    HTML: 206
  • FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator

    Claudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, Katia Falasca
    e2025057
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.057
    2095
    PDF: 853
    HTML: 302
  • Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

    Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani
    e2010035
    2010-12-13
    https://doi.org/10.4084/mjhid.2010.035
    892
    PDF: 559
    HTML: 2180
    Cover Letter: 175
  • EFFICACY AND SAFETY OF THALIDOMIDE IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVALUATION

    Jialian Li, Ping Ji, Qinyue Zhong, Lin Dong, Hai Yi, Baiyu Chen, Xu Zhang, Tingting Duan
    e2026033
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.033
    10
    PDF: 8
    Suppl. Files: 0
    HTML: 2
  • PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

    Ugo Testa; Giuseppe G.M. Leone
    e2025005
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.005
    2378
    HTML: 252
    PDF: 827
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3247
    PDF: 1208
    HTML: 2177
  • MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

    Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan
    e2015001
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.001
    2214
    PDF: 1298
    HTML: 17060
    Bassan Fig.1: 133
    Bassan Fig.2: 131
    Bassan Fig.4: 126
    Fig.3: 164
  • FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

    Alessia Castellino, Umberto Vitolo
    e2017009
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.009
    4323
    PDF: 1581
    HTML: 3412
    Tables and Images: 197
  • SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

    Galila F Zaher, Soheir S Adam
    e2012021
    2012-04-02
    https://doi.org/10.4084/mjhid.2012.021
    1247
    PDF: 874
    HTML: 3577
  • Assessment of cabin crew awareness about malaria in a major airline

    Soha Shawqi Albayat, DR., Suresh B Kokku, DR., Hamad Eid Al-Romaihi, DR., Devendra Bansal, Hayat Salahaldin Khogali, DR., Elmoubasher Farag, DR.
    e2019049
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.049
    1223
    PDF: 690
    HTML: 238
  • CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.

    Luciana Teofili, Immacolata Izzi, Eugenia Rosa Nuzzolo, Giancarlo Scoppettuolo, Katleen de Gaetano Donati, Lorenza Torti, Marianna Rossi
    e2012062
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.062
    1582
    PDF: 700
    HTML: 1625
  • COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA.

    Monia Marchetti , Robert Peter Gale, Giovanni Barosi
    Page e2021034
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.034
    1382
    PDF: 486
    HTML: 169
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2328
    PDF: 825
    HTML: 2440
  • PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

    Anna Falanga, Laura Russo, Carmen J Tartari
    e2011068
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.068
    1729
    PDF: 781
    HTML: 10209
    Figures 1,2,3: 152
  • ITPA POLYMORPHISMS AND THE INCIDENCE OF TOXICITIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Patpetra Svasdisant, Waraporn Glomglao, Preeyanun Siraprapapat, Wiyakan Inthararujikul , Kalaya Tachavanich, Chetsada Boonthimat, Sakkarin Ardsiri, Kochpinchon Chansing, Suwimon Sriprach , Sasima Tongsai , Phakatip Sinlapamongkolkul , Kleebsabai Sanpakit , Jassada Buaboonnam
    e2023024
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.024
    933
    PDF: 866
    HTML: 330
  • HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE

    Roberto Ria, Franco Dammacco, Angelo Vacca
    e2018011
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.011
    5028
    PDF: 1577
    HTML: 1336
101 - 150 of 490 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy